Delivery Order SPE2DB20D1100-SPE2DB25FC7L0
- Not listed
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $6,844.76 to AmerisourceBergen Drug Corp for AZSTARYS CAPS 39.2MG/7.8MG on September 23, 2025, with completion expected by September 24, 2025. This competitively awarded, firm fixed-price contract requires no set-aside designation and represents a pharmaceutical supply delivery to support federal medical procurement requirements. The award was placed of performance at AmerisourceBergen's corporate office...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $3,856.69 to AmerisourceBergen Drug Corp for AZSTARYS CAPS 39.2MG/7.8MG on August 20, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of August 21, 2025. This delivery order is issued under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,034.80 by the Defense Logistics Agency (DLA) on September 9, 2025, with completion expected by September 10, 2025. The contract, issued under a firm fixed-price arrangement with no set-aside designation, calls for the delivery of Azstarys 39.2 mg-7.8 mg capsules (100-count units), a prescription medication used to treat...
- This is a $1,797.13 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of AZSTARYS 52.3 MG-10.4 MG CAP 100S, a pharmaceutical product, with a performance period ending on May 22, 2025. The contract is a firm fixed-price arrangement and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
- This federal contract award, valued at $1,259.42, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the medication AZSTARYS 39.2 MG-7.8 MG CAP 100S, with a completion date of April 21, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
- This is a $1,304.01 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of AZSTARYS 39.2 MG-7.8 MG CAP 100S, a pharmaceutical product, with a performance period ending on February 13, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- The Defense Logistics Agency awarded a $5,531.10 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Azstarys 26.1 mg–5.2 mg capsules (100 count). This is a non-set-aside competitive award with an ultimate completion date of August 15, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support...
- This is a firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Medical Supply Chain. The $2,959.88 contract is for the delivery of the medication AZSTARYS CAPS 39.2MG/7.8MG. This order is part of Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which runs through December 2026. This IDC serves as a comprehensive global...
- This is a firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract has a ceiling value of $3,017.85 and covers the delivery of the medication AZSTARYS 26.1 MG-5.2 MG CAP 100S. The contract is not set aside and has an ultimate completion date of June 18, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,277.09, is for the provision of AZSTARYS CAPS 52.3MG/10.4MG, a pharmaceutical product. The award has an ultimate completion date of January 7, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FC7L0Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,921.48 to AmerisourceBergen Drug Corp for 100 capsules of AZSTARYS 26.1 mg-5.2 mg, a prescription medication. The contract was competitively awarded without a set-aside designation and carries a firm fixed price structure. Performance will be executed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of June 9, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, supplying medications and medical commodities to military and veteran healthcare systems. As a major healthcare solutions provider headquartered in Pennsylvania and registered in the System for Award Management, the company demonstrates significant capability in meeting federal procurement requirements through open competition. The DLA utilizes AmerisourceBergen's pharmaceutical prime vendor contract to support military healthcare programs globally, enabling flexible delivery of specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.9k | 6/6/25 |